58% Margins, Net Cash, Down 15% - Here's Why I'm Interested
A debt-free, cash-rich medical-consumables business got marked down for a timing-driven quarter - and the customer base behind it tells a different story.
To read our full disclaimer, click here.
A profitable medical-consumables microcap spent the last two years signing up hospitals faster than its revenue could show it.
58% gross margins - 500 to 1,000+ basis points above its much larger peers.
Completely debt-free, with net cash worth roughly a third of the market cap.
A $4 million special dividend paid last quarter, and the cash balance still went up.
99% retention of its top-50 hospital accounts.
Two system-wide approvals at major US hospital networks, one with more than 300 sites of care.
Roughly 50% insider ownership, with the board alone holding about half the shares.
Yet it trades right around 1x revenue.
The reason comes down to a single quarter. The company just reported revenue down 15% year over year - a genuinely soft print - and the market took that as the whole story.
I think that’s the mistake. The quarter wasn’t a broken business, it was order timing. Management disclosed that sales and firm orders booked in just the first six weeks of the current quarter had already passed the entire prior quarter’s revenue.
So the downside here is a debt-free, cash-rich, high-margin business. The upside is what happens when one timing quarter stops being the headline.
That’s the asymmetry I look for.
The company is...